The New Criterion

Acrux (ACR) 17c By turning to generic drug making, Acrux Ltd, the provider of the roll-on testosterone treatment Axiron, is taking a different path to jump start its fading fortunes. Or is it? CEO Michael Kotsanis argues his company is…